Mesa Laboratories (MLAB) risk factors, FY2026 10-K

Mesa Laboratories's FY2026 10-K, filed Jun 03, 2026, lists 49 risk factors in 4 groups. Against the prior year's 48: 12 new, 11 dropped, 37 substantially reworded.

Risk factors listed
494 groups
New this year
12vs 48 last year
Dropped
11since the prior 10-K
Substantially reworded
37of those kept
Section length
10k wordsItem 1A

What the changes say

  • New risks focus on supply-chain disruption, tariffs, FDA and cybersecurity compliance, and the March 2026 CEO transition.
  • Mesa added AI adoption risk, cost-reduction execution risk, broader litigation, intellectual-property, currency, and debt-service concerns.
  • The section drops acquisition, stock-price, commodity-cost, and broad geopolitical risks while consolidating industry, workforce, and supply-chain themes.
  • Goodwill and intangible assets declined from $278.6 million to $270.2 million, while accounting, tax, government-contract, and international risks were refined.

What changed since the prior 10-K

New

  • NewBusiness and Strategic Risks

    Industry consolidation and shifts in customer behavior could adversely affect our results of operations

    Industry consolidation, changing customer regulations, price competition, and competing products could reduce demand or increase reliance on larger customers and suppliers.

  • NewBusiness and Strategic Risks

    Our success depends on our ability to recruit, retain and motivate skilled employees, and changes to our management team may not provide the benefits we expect

    A competitive labor market and the April 2026 CEO transition could cause employee losses, manufacturing disruption, compliance problems, backlog, and strategic uncertainty.

  • NewBusiness and Strategic Risks

    Uncertainties related to the use of artificial intelligence (“AI”) in our business may result in harm to our business and reputation

    Early-stage AI use could expose Mesa to intellectual-property, confidentiality, privacy, cybersecurity, regulatory, reputational, cost, and competitive risks.

  • NewOperational Risks

    Our financial results depend on the availability, quality and timely delivery of materials, components, services and labor required for our operations

    Supplier failures, sole-source dependence, price increases, tariffs, conflicts, disasters, or regulatory changes could delay materials, production, shipments, and revenue recognition.

  • NewOperational Risks

    Cost reduction or efficiency initiatives may not achieve anticipated benefits and may involve higher-than-expected transition or implementation costs

    Cost-reduction and efficiency initiatives may miss savings targets, incur unexpected severance or implementation costs, disrupt operations, or reduce employee morale.

  • NewLegal, Regulatory, Compliance, and Reputational Risks

    Changes in trade policies, tariffs, or industrial policies may increase our costs, disrupt our supply chain, or adversely affect demand for our products

    Changing tariffs and trade policies, including responses to the February 2026 Supreme Court ruling, could raise costs, disrupt supply, or reduce demand.

  • NewLegal, Regulatory, Compliance, and Reputational Risks

    We are subject to extensive and evolving regulatory requirements that affect the approval, manufacture, marketing and commercialization of our products

    Delays or failures in FDA 510(k) and other regulatory approvals, inspections, testing, or surveillance could restrict product launches and commercialization.

  • NewLegal, Regulatory, Compliance, and Reputational Risks

    Evolving cybersecurity regulations, including the European Union’s Cyber Resilience Act, may increase our compliance costs and require changes to our products and processes

    The EU Cyber Resilience Act and similar rules may require redesigned products, stronger controls, lifecycle support, and additional cybersecurity reporting and compliance spending.

  • NewLegal, Regulatory, Compliance, and Reputational Risks

    We are subject to lawsuits, investigations and regulatory proceedings that could result in significant costs, penalties, or liabilities

    Product, intellectual-property, employment, tax, environmental, commercial, and other lawsuits or investigations could impose damages, penalties, injunctions, and management costs.

  • NewLegal, Regulatory, Compliance, and Reputational Risks

    If we do not adequately protect our intellectual property, if third parties infringe our intellectual property rights, or if we or our customers are alleged to infringe upon others’ intellectual property rights, we may suffer competitive injury or expend significant resources enforcing or defending our rights

    Mesa may lose competitive protection or incur enforcement costs if its intellectual property is challenged, infringed, weakly protected, or subject to compulsory licensing.

  • NewFinancial and Tax Risks

    In addition, certain of our businesses invoice customers in currencies other than their functional currency, and changes in exchange rates between the invoicing currency and the functional currency may result in unfavorable remeasurement effects

    Foreign-currency invoice remeasurement and translation effects may hurt results because Mesa does not hedge exchange-rate exposure.

  • NewFinancial and Tax Risks

    Servicing our debt will require a significant amount of cash, and deterioration in our financial performance or in global credit market conditions could adversely affect our ability to obtain financing or to fund our existing debt obligations

    Significant Credit Facility debt, variable interest rates, weaker performance, or tighter credit markets could limit cash available for debt service or refinancing.

Dropped

  • DroppedBusiness and Strategic Risks

    greater uncertainty, risk, expense and delay in commercializing products in certain foreign jurisdictions, including with respect to product and other regulatory approvals

  • DroppedBusiness and Strategic Risks

    Changing industry trends may affect our results of operations

  • DroppedBusiness and Strategic Risks

    If we are unable to continue to hire and retain skilled personnel, we will have difficulty manufacturing and marketing our products

  • DroppedOperational Risks

    Significant developments or uncertainties related to social, political, regulatory and economic matters within the U.S. and internationally, including with respect to international trade policies and tariffs, could have an adverse effect on our business

    Foreign-jurisdiction commercialization, diplomatic, regulatory, and international-sales risks, including China and other non-domestic operations.

  • DroppedOperational Risks

    Supply chain and manufacturing risks could adversely affect our financial results. In addition, our reliance upon sole or limited sources of supply for certain materials, components and services could cause production interruptions, delays and inefficiencies

  • DroppedOperational Risks

    Our financial results are subject to fluctuations in the cost and availability of components and commodities that we use in our operations

  • DroppedOperational Risks

    Our acquisitions of businesses expose us to risks that could negatively impact our financial results

    Industry trends, customer consolidation, changing practices, price competition, and competing products affecting demand.

  • DroppedLegal, Regulatory, Compliance, and Reputational Risks

    We are subject to lawsuits and regulatory proceedings

  • DroppedLegal, Regulatory, Compliance, and Reputational Risks

    We are subject to extensive regulation

    Difficulty hiring and retaining personnel could disrupt manufacturing, compliance, marketing, and backlog management.

  • DroppedFinancial and Tax Risks

    The cost and availability of credit are subject to changes in the global economic environment. If conditions in major credit markets deteriorate, our ability to obtain debt financing or the terms associated with that debt financing may be negatively affected, which could affect our results of operations

  • DroppedFinancial and Tax Risks

    our results of operations and financial performance

    Broad U.S. and international social, political, regulatory, economic, healthcare, manufacturing, and trade-policy uncertainty.

Reworded

  • 97% rewrittenFinancial and Tax Risks

    Changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters could affect our reported financial results

    The revised risk removes the internal-controls and fraud discussion, narrows accounting examples, and continues warning that standards or management estimates could materially change results.

  • 95% rewrittenLegal, Regulatory, Compliance, and Reputational Risks

    Our reputation, ability to do business and prepare financial statements may be impaired by improper conduct by any of our employees, agents or business partners

    The revised risk focuses solely on improper conduct, adding explicit operational, financial-reporting, enforcement, penalty, reputational, and compliance-cost consequences.

  • 95% rewrittenFinancial and Tax Risks

    Changes in tax law relating to multinational corporations could adversely affect our tax position

    The revised risk emphasizes OECD base-erosion measures already adopted by taxing authorities and adds prospective or retroactive tax changes and effective-rate effects.

  • 94% rewrittenLegal, Regulatory, Compliance, and Reputational Risks

    We are subject to laws and regulations governing government contracts

    The revised risk adds possible government-contract termination and clarifies reviews, investigations, penalties, and debarment consequences for noncompliance.

  • 93% rewrittenFinancial and Tax Risks

    We may be required to recognize impairment losses for our goodwill and other intangible assets

    Goodwill and intangible assets decreased from $278.6 million to $270.2 million; the revised text adds past impairment losses, major tariffs, and weighted-average-cost-of-capital increases as triggers.

  • 92% rewrittenLegal, Regulatory, Compliance, and Reputational Risks

    Off-label marketing of our products could result in substantial penalties

    The revised risk broadens off-label exposure from FDA action to other regulators and adds criminal or civil penalties, disgorgement, and operational curtailment.

  • 91% rewrittenBusiness and Strategic Risks

    Our international operations subject us to a wide range of risks

    The revised international-risk list adds weaker foreign intellectual-property and data protection, counterfeiting, and greater significance relative to U.S. operations.

  • 91% rewrittenLegal, Regulatory, Compliance, and Reputational Risks

    Certain modifications to our products may require new 510(k) clearances or other marketing authorizations and may require us to recall or cease marketing our products

    The revised risk more directly covers recalled or halted modified products and adds significant regulatory fines or penalties if new clearance is required.

  • 90% rewrittenFinancial and Tax Risks

    Additional stock issuances could result in significant dilution to our stockholders

  • 90% rewrittenFinancial and Tax Risks

    Foreign currency exchange rates may adversely affect our financial statements

  • 89% rewrittenFinancial and Tax Risks

    Failure to maintain appropriate corporate responsibility practices and disclosures could result in reputational harm, a loss of customer and investor confidence, and adverse business and financial results

    Was: Our failure to maintain appropriate corporate responsibility practices and disclosures could result in reputational harm, a loss of customer and investor confidence, and adverse business and financial results

  • 88% rewrittenOperational Risks

    Geopolitical pressures in the markets in which we operate may adversely affect our financial results

    Was: Geopolitical and macroeconomic pressures in the markets in which we operate may adversely affect our financial results

  • 83% rewrittenFinancial and Tax Risks

    The loss of key customers, or reductions in their demand for our products and services, could have a significant adverse effect on our revenues, results of operations, and financial position

    Was: The loss of key customers, or reductions in their demand for our products and services, could have a significant negative impact on our revenues, results of operations, and financial position

  • 83% rewrittenBusiness and Strategic Risks

    The markets for our current and potential products are competitive. Because of the breadth of our product and service offerings and the variety of markets we serve, we compete against a wide range of competitors, including several that possess larger sales forces and greater capital resources

    Was: The markets for our current and potential products are competitive. Because of the range of products and services we sell and the variety of markets we serve, we encounter a wide variety of competitors, including several that possess both larger sales forces and greater capital resources

  • 83% rewrittenOperational Risks

    Climate change, as well as legal or regulatory measures and stakeholder expectations related to climate change and sustainability, may negatively affect our business and financial results, and any actions we take or fail to take in response to such matters could damage our reputation

    Was: Climate change, or legal or regulatory measures to address climate change and sustainability, may negatively affect us, and any actions we take or fail to take in response to such matters could damage our reputation

  • 82% rewrittenOperational Risks

    The manufacture of many of our products is a highly exacting and complex process, and if we directly or indirectly encounter problems manufacturing products, our reputation, business and financial results could suffer

  • 80% rewrittenOperational Risks

    The life sciences, pharmaceutical, healthcare and related industries we serve have undergone, and continue to undergo, significant changes in an effort to reduce costs, which could adversely affect our financial results

    Was: The life sciences and healthcare industries and related industries that we serve have undergone, and are in the process of undergoing, significant changes in an effort to reduce costs, which could adversely affect our financial results

  • 80% rewrittenFinancial and Tax Risks

    Changes in our tax rates or exposure to additional income tax liabilities or assessments could affect our profitability. In addition, audits by tax authorities could result in additional tax payments for prior periods

  • 79% rewrittenOperational Risks

    We may be unable to efficiently manage our growth as a larger and more geographically diverse organization

  • 78% rewrittenOperational Risks

    A significant disruption in, or breach in security of, our information technology systems or data could adversely affect our business, reputation and financial statements

  • 76% rewrittenLegal, Regulatory, Compliance, and Reputational Risks

    Changes in governmental regulations or regulatory enforcement may reduce demand for our products or services or increase our expenses

    Was: Changes in governmental regulations may reduce demand for our products or services or increase our expenses

  • 74% rewrittenOperational Risks

    If we suffer loss to our facilities, supply chains, distribution systems or information technology systems due to a catastrophic event, our operations could be seriously harmed

  • 73% rewrittenBusiness and Strategic Risks

    Adverse changes in our relationships with, or the financial condition, performance, or purchasing patterns of, distributors and other channel partners could adversely affect our business, results of operations, and financial condition

    Was: Adverse changes in our relationships with, or the financial condition, performance, purchasing patterns or inventory levels of, distributors and other channel partners could adversely affect our financial statements

  • 73% rewrittenBusiness and Strategic Risks

    Our growth depends in part on the timely development, commercialization, and customer acceptance of new and enhanced products and services based on technological innovation

  • 67% rewrittenBusiness and Strategic Risks

    adversely impacting market sizes and growth rates

  • 67% rewrittenFinancial and Tax Risks

    The market price of our common stock may be volatile, which may subject us to securities class action litigation or cause shareholders to lose part or all of their investment

    Was: Our stock price may be volatile, which may subject us to a securities class action litigation or could cause shareholders to lose part or all of their investment

  • 67% rewrittenLegal, Regulatory, Compliance, and Reputational Risks

    We are subject to export and import control laws and regulations that could impair our ability to compete in international markets or subject us to liability if we violate such laws and regulations

  • 66% rewrittenOperational Risks

    The indemnification provisions of acquisition agreements by which we have acquired companies may not fully protect us, which could result in unexpected liabilities

    Was: The indemnification provisions of acquisition agreements by which we have acquired companies may not fully protect us and as a result we may face unexpected liabilities, or we may have acquisition agreements with no indemnification protection at all

  • 65% rewrittenOperational Risks

    Violation of data privacy laws could adversely affect our business, reputation and financial statements

  • 65% rewrittenOperational Risks

    Future strategic transactions or acquisitions may require us to seek additional financing, which we may not be able to secure on favorable terms, or at all

  • 64% rewrittenBusiness and Strategic Risks

    Our growth could suffer if the markets into which we sell our products and services decline, do not grow as anticipated or experience volatility

  • 64% rewrittenFinancial and Tax Risks

    declines in the trading price of our common stock

    Was: negative impact on the trading price of our common stock

  • 61% rewrittenOperational Risks

    Any inability to consummate acquisitions at our historical rate and at appropriate prices could negatively impact our growth rate and stock price

  • 60% rewrittenOperational Risks

    Changes to dialysis methods and equipment capabilities may decrease demand for our renal care products and negatively impact our business, results of operations, and financial condition

    Was: Changes to dialysis methods and equipment capabilities may decrease demand for our renal care products and negatively impact our financial statements

  • 55% rewrittenLegal, Regulatory, Compliance, and Reputational Risks

    Potential product liability suits against us, product defects, unanticipated use or inadequate disclosure related to our products or services could adversely affect our business, reputation, results of operations, and financial condition

    Was: Potential product liability suits against us, product defects or unanticipated use or inadequate disclosure with respect to our products or services could adversely affect our business, reputation and our financial statements

  • 55% rewrittenFinancial and Tax Risks

    Our business is subject to sales tax in numerous states

  • 37% rewrittenBusiness and Strategic Risks

    Conditions in the global economy, the markets we serve, and financial markets may adversely affect our business, financial statements, and access to capital markets

All 49 risk factors

Headings as the filing states them, in filing order.

Business and Strategic Risks

  1. 01Conditions in the global economy, the markets we serve, and financial markets may adversely affect our business, financial statements, and access to capital markets37% rewritten
  2. 02adversely impacting market sizes and growth rates67% rewritten
  3. 03Our international operations subject us to a wide range of risks91% rewritten
  4. 04Our growth could suffer if the markets into which we sell our products and services decline, do not grow as anticipated or experience volatility64% rewritten
  5. 05The markets for our current and potential products are competitive. Because of the breadth of our product and service offerings and the variety of markets we serve, we compete against a wide range of competitors, including several that possess larger sales forces and greater capital resources83% rewritten
  6. 06Industry consolidation and shifts in customer behavior could adversely affect our results of operationsNew
  7. 07Our growth depends in part on the timely development, commercialization, and customer acceptance of new and enhanced products and services based on technological innovation73% rewritten
  8. 08Our success depends on our ability to recruit, retain and motivate skilled employees, and changes to our management team may not provide the benefits we expectNew
  9. 09Adverse changes in our relationships with, or the financial condition, performance, or purchasing patterns of, distributors and other channel partners could adversely affect our business, results of operations, and financial condition73% rewritten
  10. 10Uncertainties related to the use of artificial intelligence (“AI”) in our business may result in harm to our business and reputationNew

Operational Risks

  1. 11Geopolitical pressures in the markets in which we operate may adversely affect our financial results88% rewritten
  2. 12A significant disruption in, or breach in security of, our information technology systems or data could adversely affect our business, reputation and financial statements78% rewritten
  3. 13Our financial results depend on the availability, quality and timely delivery of materials, components, services and labor required for our operationsNew
  4. 14We may be unable to efficiently manage our growth as a larger and more geographically diverse organization79% rewritten
  5. 15Cost reduction or efficiency initiatives may not achieve anticipated benefits and may involve higher-than-expected transition or implementation costsNew
  6. 16The life sciences, pharmaceutical, healthcare and related industries we serve have undergone, and continue to undergo, significant changes in an effort to reduce costs, which could adversely affect our financial results80% rewritten
  7. 17The manufacture of many of our products is a highly exacting and complex process, and if we directly or indirectly encounter problems manufacturing products, our reputation, business and financial results could suffer82% rewritten
  8. 18Changes to dialysis methods and equipment capabilities may decrease demand for our renal care products and negatively impact our business, results of operations, and financial condition60% rewritten
  9. 19Violation of data privacy laws could adversely affect our business, reputation and financial statements65% rewritten
  10. 20If we suffer loss to our facilities, supply chains, distribution systems or information technology systems due to a catastrophic event, our operations could be seriously harmed74% rewritten
  11. 21Climate change, as well as legal or regulatory measures and stakeholder expectations related to climate change and sustainability, may negatively affect our business and financial results, and any actions we take or fail to take in response to such matters could damage our reputation83% rewritten
  12. 22Any inability to consummate acquisitions at our historical rate and at appropriate prices could negatively impact our growth rate and stock price61% rewritten
  13. 23The indemnification provisions of acquisition agreements by which we have acquired companies may not fully protect us, which could result in unexpected liabilities66% rewritten
  14. 24Future strategic transactions or acquisitions may require us to seek additional financing, which we may not be able to secure on favorable terms, or at all65% rewritten

Legal, Regulatory, Compliance, and Reputational Risks

  1. 25Changes in trade policies, tariffs, or industrial policies may increase our costs, disrupt our supply chain, or adversely affect demand for our productsNew
  2. 26We are subject to extensive and evolving regulatory requirements that affect the approval, manufacture, marketing and commercialization of our productsNew
  3. 27Evolving cybersecurity regulations, including the European Union’s Cyber Resilience Act, may increase our compliance costs and require changes to our products and processesNew
  4. 28Off-label marketing of our products could result in substantial penalties92% rewritten
  5. 29Certain modifications to our products may require new 510(k) clearances or other marketing authorizations and may require us to recall or cease marketing our products91% rewritten
  6. 30Changes in governmental regulations or regulatory enforcement may reduce demand for our products or services or increase our expenses76% rewritten
  7. 31Potential product liability suits against us, product defects, unanticipated use or inadequate disclosure related to our products or services could adversely affect our business, reputation, results of operations, and financial condition55% rewritten
  8. 32We are subject to lawsuits, investigations and regulatory proceedings that could result in significant costs, penalties, or liabilitiesNew
  9. 33Our reputation, ability to do business and prepare financial statements may be impaired by improper conduct by any of our employees, agents or business partners95% rewritten
  10. 34If we do not adequately protect our intellectual property, if third parties infringe our intellectual property rights, or if we or our customers are alleged to infringe upon others’ intellectual property rights, we may suffer competitive injury or expend significant resources enforcing or defending our rightsNew
  11. 35We are subject to export and import control laws and regulations that could impair our ability to compete in international markets or subject us to liability if we violate such laws and regulations67% rewritten
  12. 36We are subject to laws and regulations governing government contracts94% rewritten

Financial and Tax Risks

  1. 37Foreign currency exchange rates may adversely affect our financial statements90% rewritten
  2. 38In addition, certain of our businesses invoice customers in currencies other than their functional currency, and changes in exchange rates between the invoicing currency and the functional currency may result in unfavorable remeasurement effectsNew
  3. 39The loss of key customers, or reductions in their demand for our products and services, could have a significant adverse effect on our revenues, results of operations, and financial position83% rewritten
  4. 40declines in the trading price of our common stock64% rewritten
  5. 41We may be required to recognize impairment losses for our goodwill and other intangible assets93% rewritten
  6. 42Changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters could affect our reported financial results97% rewritten
  7. 43Changes in our tax rates or exposure to additional income tax liabilities or assessments could affect our profitability. In addition, audits by tax authorities could result in additional tax payments for prior periods80% rewritten
  8. 44Changes in tax law relating to multinational corporations could adversely affect our tax position95% rewritten
  9. 45Our business is subject to sales tax in numerous states55% rewritten
  10. 46Servicing our debt will require a significant amount of cash, and deterioration in our financial performance or in global credit market conditions could adversely affect our ability to obtain financing or to fund our existing debt obligationsNew
  11. 47Additional stock issuances could result in significant dilution to our stockholders90% rewritten
  12. 48The market price of our common stock may be volatile, which may subject us to securities class action litigation or cause shareholders to lose part or all of their investment67% rewritten
  13. 49Failure to maintain appropriate corporate responsibility practices and disclosures could result in reputational harm, a loss of customer and investor confidence, and adverse business and financial results89% rewritten

Other Mesa Laboratories 10-Ks

  • FY2025 10-K risk factors
    48 risks

    Mesa Laboratories faces intense market competition, strict FDA and international regulatory requirements, and integration risks from strategic business acquisitions. Significant revenue concentration relies on key customers, distributors, and specific product lines like Dialyguard.

    Filed May 28, 2025

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.